Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia (Q73748127)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2000

Language	Label	Description	Also known as
English	Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia	scientific article published on 01 January 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797611%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

author name string

L A Salazar

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

M H Hirata

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

E C Quintão

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

R D Hirata

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797611%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Journal of Clinical Laboratory Analysis

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

125-131

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biopharmaceutical profile of cerivastatin: a novel HMG-CoA reductase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haplotype analysis at the low density lipoprotein receptor locus: application to the study of familial hypercholesterolemia in Israel

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG-CoA reductase inhibitors: an exciting development in the treatment of hyperlipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pvu II intron 15 polymorphism at the LDL receptor gene is associated with differences in serum lipid concentrations in subjects with low and high risk for coronary artery disease from Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RFLPs of the LDL-receptor gene: Their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin: a review of its use in lipid disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid risk factors and the regression of atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of the low density lipoprotein receptor gene PvuII intron 15 polymorphism using the polymerase chain reaction: association with plasma lipid traits in healthy men and women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A three-allelic polymorphic system in exon 12 of the LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish population

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10797611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/(SICI)1098-2825(2000)14:3<125::AID-JCLA7>3.0.CO;2-S

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807834&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73748127&oldid=1752571889"